DACOMITINIB
UNII 5092U85G58

Substance Identification & Data

This profile provides standardized clinical and technical data for Dacomitinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5092U85G58.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1042385-75-0 and the RxNorm Concept ID (RxCUI) 2058849. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

5092U85G58

CAS Registry Number

1042385-75-0

RxNorm Concept ID

2058849

Detailed Substance Profile

Preferred Name

DACOMITINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

5092U85G58

The specific atomic composition represented as a molecular structure string.

InChIKey

C24H25ClFN5O2.H2O

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

BSPLGGCPNTZPIH-IPZCTEOASA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C53398

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

70693519

Unique identification number in the NCBI database of chemical substances.

USAN ID

WW-138

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1CCCN(C1)C\C=C\C(Nc2c(cc3c(c(Nc4ccc(c(c4)Cl)F)ncn3)c2)OC)=O.O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dacomitinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.